Matrix metalloproteinases and their regulators are cardiovascular therapeutic targets

Journal of Molecular Medicine

Volumn 82, Issue 12, 2004, Pages 781-783

  Luft, Friedrich C ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHIN; DOXYCYCLINE; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

AMINO ACID SEQUENCE; AORTA ANEURYSM; AORTA STENOSIS; CARDIOVASCULAR DISEASE; DRUG TARGETING; ENZYME ACTIVITY; HEART VENTRICLE WALL; HUMAN; NONHUMAN; PROTEIN EXPRESSION; SHORT SURVEY; VASCULAR TISSUE;

AORTIC VALVE STENOSIS; CARDIOVASCULAR DISEASES; FIBROSIS; HUMANS; MATRIX METALLOPROTEINASES; MYOCARDIUM; PROTEIN STRUCTURE, TERTIARY; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 12444270048     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-004-0609-1     Document Type: Short Survey

References (10)

1. Fielitz J, Leuschner M, Zurbrügg HR, Hannack B, Pregla R, Hetzer R, Regitz-Zagrosek V (2004) Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis. J Mol Med (http://dx.doi.org/10.1007/s00109-004-0606-4)
2. Kaden JJ, Dempfle CE, Grobholz R, Tran HT, Kilic R, Sarikoc A, Brueckmann M, Vahl C, Hagl S, Haase KK, Borggrefe M (2003) Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis 170:205-211
3. Satta J, Oiva J, Salo T, Eriksen H, Ohtonen P, Biancari F, Juvonen TS, Soini Y (2003) Evidence for an altered balance between matrix metalloproteinase-9 and its inhibitors in calcific aortic stenosis. Ann Thorac Surg 76:681-688
4. Lombardi R, Betocchi S, Losi MA, Tocchetti CG, Aversa M, Miranda M, D'Alessandro G, Cacace A, Ciampi Q, Chiariello M (2003) Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 108:1455-1460
5. Chase AJ, Newby AC (2003) Regualtion of matrix metalloproteinase (Matrixin) genes in blood vessels: a multistep recruitment model for pathological remodeling. J Vasc Res 40:329-343
6. Kuzuya M, Iguchi A (2003) Role of matrix metalloproteinases in vascular remodeling. J Atheroscler Thromb 10:275-282
7. Tsuruda T, Costello-Boerrigter LC, Burnett JC (2004) Matrix metalloproteinases: pathways of induction by bioactive molecules. Heart Failure Rev 9:53-61
8. Peterson JT (2004) Matrix metalloproteinase inhibitor development and the remodeling of drug discovery. Heart Fail Rev 9:63-79
9. Kadoglou NP, Liapis CD (2004) Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. Curr Med Res Opin 26:419-432
10. Maeda K, Kuzuya M, Cheng XWW, Asai T, Kanda S, Tamaya-Mori N, Sasaki T, Shibata T, Iguchi A (2003) Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier. Atherosclerosis 166:23-30